65岁以下主动脉瓣狭窄患者主动脉瓣置换方式选择的医院差异
本研究基于美国3州2013至2021年数据,评估医院对65岁以下重度主动脉瓣狭窄患者TAVR使用偏好对临床结局的影响。高TAVR使用率医院的患者30天永久起搏器植入率更高,6年风险调整死亡、卒中和感染性心内膜炎风险均更高。
要点
- 高TAVR使用率医院患者30天永久起搏器植入率17%,高于中、低使用率医院的7.6%和5.6%。
- 高 vs 低TAVR使用率医院6年风险调整死亡风险HR 1.63(1.37-1.93),卒中sHR 2.15(1.50-3.06),感染性心内膜炎sHR 9.91(5.59-17.56)。
- 65岁以下患者TAVR决策需结合临床特征和预期寿命谨慎考虑。
核心结论
- 在65岁以下重度主动脉瓣狭窄患者中,高TAVR使用率医院的患者6年死亡、卒中和感染性心内膜炎风险更高。
- TAVR在该人群中的应用决策应结合患者临床特征和预期寿命谨慎考虑。
研究设计与样本
- 基于美国3州2013至2021年数据的回顾性队列研究。
- 通过观察值与预期值之比生成医院TAVR偏好,将189家医院按比值三分位分组。
- 低、中、高三分位医院分别为103、55、31家。
主要发现
- 高三分位医院患者合并症率低于中、低三分位医院。
- 高、中、低三分位医院30天永久起搏器植入率分别为17%、7.6%、5.6%(P < .001)。
- 高 vs 低三分位医院6年风险调整死亡率为8.1% vs 5.3%(HR 1.63 [1.37-1.93],P < .001)。
- 高 vs 低三分位医院6年卒中率为2.2% vs 1.1%(sHR 2.15 [1.50-3.06],P < .001)。
- 高 vs 低三分位医院6年感染性心内膜炎率为2.9% vs 0.3%(sHR 9.91 [5.59-17.56],P < .001)。
临床怎么用
- 对65岁以下重度主动脉瓣狭窄患者选择TAVR时应评估医院TAVR使用偏好及患者预期寿命。
- 需关注高TAVR使用率医院患者术后永久起搏器植入、死亡、卒中和感染性心内膜炎风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Although surgical aortic valve replacement (SAVR) has a class 1 A recommendation for treating severe aortic stenosis in patients <65 years, transcatheter aortic valve replacement (TAVR) in this population is increasing. This study evaluates the impact of hospital variation in TAVR use in patients <65 years on clinical outcomes. METHODS: Using US 3-state data from 2013 through 2021, we assessed the hospitals' preference for TAVR vs SAVR by generating the observed-to-expected TAVR ratio. Hospitals were ranked into tertiles based on their ratio. The risk of mortality, stroke, infective endocarditis (IE), and permanent pacemaker implantation (PPI) for patients undergoing aortic valve replacement (AVR) in each tertile was assessed at 30 days and 6 years using logistic regression and Cox-proportional hazard models. RESULTS: Among 189 hospitals, 103 were in the low, 55 in the medium, and 31 in the high-tertile. Patients who underwent AVR in the high tertile had lower rates of comorbidities than patients in mid or low tertiles. Patients at high and medium ratio hospitals had higher rates of PPI at 30 days than those from low TAVR-use hospitals (17% vs 7.6% vs 5.6%, P < .001). Patients in the high vs low tertile experienced a higher 6-year risk-adjusted mortality (8.1% vs 5.3%, HR: 1.63 [1.37-1.93], P < .001), stroke (2.2% vs 1.1%, sub-distribution hazard ratio [sHR]: 2.15 [1.50-3.06], P < .001), and IE (2.9% vs 0.3%, sHR: 9.91 [5.59-17.56], P < .001). CONCLUSIONS: The decision on TAVR utilization in patients younger than 65 should be made carefully considering the patient's clinical profile and life expectancy.
引用
- Alabbadi S, Sallam A, Tam D, et al. Hospital Variation in Aortic Valve Replacement Approach Selection for Aortic Stenosis in Patients Under 65. Eur J Cardiothorac Surg. 2025. PMID: 41143537. doi:10.1093/ejcts/ezaf371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。